metoprolol has been researched along with Anemia, Hemolytic in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabbani, M | 1 |
| Hafiz, A | 1 |
| Algadheeb, M | 1 |
| Thain, A | 1 |
| Kiaii, BB | 1 |
1 other study available for metoprolol and Anemia, Hemolytic
| Article | Year |
|---|---|
A Case of Systolic Anterior Motion After Mitral Valve Repair Causing Hemolytic Anemia: Mechanism and Treatment.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anemia, Hemolytic; Echocardiography, Transesophageal; | 2020 |